Titanium dioxide (E171), a commonly used food additive prized for its brilliant white pigment, has long been assumed safe, hiding quietly in everyday products from chewing gums and sweets to pastries and salad dressings.1 Despite its ubiquity, recent scientific scrutiny reveals unsettling gaps in our knowledge, highlighting how regulatory decisions often lag behind evolving evidence.
In the United States, titanium dioxide is extensively used across a wide range of processed foods and beverages, making it nearly ubiquitous in the average American diet. Common sources include dairy products such as yogurt and ice cream, confectionery like candies and chewing gums, bakery goods such as pastries, cookies, and cakes, as well as sauces, salad dressings, and processed snacks. Its prevalence is largely driven by consumer preferences for visually appealing, bright white or vibrantly colored food products, underscoring the additive’s pervasive role in food manufacturing.
Fig. Processed foods that are made white via titanium dioxide.
Historically, titanium dioxide enjoyed widespread acceptance based on assumptions of inertness and stability. However, this comfort began eroding in 2010 when the International Agency for Research on Cancer (IARC) classified titanium dioxide as a “possible carcinogen” (Group 2B), citing animal studies primarily on inhalation exposure.2 While this evaluation didn’t directly address dietary risks, it opened regulatory eyes to potential hazards associated with nanoscale particles, triggering reconsideration of food-grade formulations.
A decisive turn came in 2021 when the European Food Safety Authority (EFSA) concluded it could not confirm the safety of dietary E171 due to unresolved genotoxicity concerns.3
n Recital 11, the European Food Safety Authority concluded that “a concern for genotoxicity could not be ruled out” and, given the remaining uncertainties, “titanium dioxide (E 171) can no longer be considered safe when used as a food additive.”¹ The Commission then acted decisively. Recital 12 states that “it is appropriate to remove the authorisation to use titanium dioxide (E 171) in foods. Accordingly, titanium dioxide (E 171) may no longer be used in foods.”¹ This is not a warning label, not a usage restriction, not a dosage adjustment — it is removal of authorization. Even more revealing is Recital 13, which clarifies that the Authority “did not identify an immediate health concern,” yet still mandated withdrawal to allow a transitional period.¹ In other words, the EU did not wait for overt harm. It acted because genotoxicity could not be excluded. That distinction matters: regulatory science here treated unresolved DNA-damage potential as disqualifying for continued food use. The operative legal language in Article 2 then formalized the phase-out, allowing foods produced before 7 February 2022 to remain on the market only until 7 August 2022, and thereafter only until their date of minimum durability.¹ The record is clear — uncertainty about genotoxicity was sufficient grounds for prohibition.
This landmark ruling effectively reversed previous assurances, compelling the European Union to ban E171 from food products by early 2022.4 Notably, EFSA’s stance emphasized a crucial scientific principle: uncertainty about genotoxic risks implies that “absence of evidence is not evidence of absence.”
Conversely, other international regulators have resisted similar action. Food Standards Australia New Zealand (FSANZ) reviewed largely the same data but concluded there was insufficient evidence to warrant restricting dietary titanium dioxide.5 In the U.S., the Food and Drug Administration (FDA) continues to permit E171, maintaining traditional safety standards that predate more recent toxicological insights.6 This stark regulatory divergence illustrates how identical data can yield vastly different policy outcomes based on underlying assumptions about risk, uncertainty, and precaution.
Animal studies have further complicated this regulatory landscape. In rats, prolonged dietary exposure to titanium dioxide has been linked to immune disruption, chronic intestinal inflammation, and precancerous lesions. For instance, Bettini et al. (2017) observed significant increases in aberrant crypt formations—preneoplastic lesions—in rat colons, coupled with immune system dysregulation after exposure to E171.7 Such findings underscore the biological plausibility of harm at doses close to typical human dietary exposures.
Further animal studies show that titanium dioxide disrupts gut microbiota composition, leading to increased inflammatory responses. Cao et al. (2020) demonstrated that dietary titanium dioxide exposure altered microbiome populations and inflammatory profiles in mice, mediated explicitly through microbiota changes.8 Such mechanistic insights offer a worrying glimpse into potential chronic human health impacts, challenging assumptions about E171’s inertness.
Yet, the critical gap remains human evidence. Absence of long-term human epidemiological studies means direct proof linking dietary E171 to specific human health outcomes is lacking. However, as EFSA’s assessment emphasizes, absence of evidence cannot reassure us of safety, particularly when mechanistic pathways for potential harm are well-demonstrated in animal models.
Material Safety Data Sheets (MSDS) on titanium dioxide primarily detail workplace risks, focusing predominantly on inhalation hazards and acute irritations.9-11 Such sheets typically overlook chronic dietary risks and genotoxicity findings, leaving a significant informational void for consumers and policymakers alike.
Adding complexity is the issue of independence in research. Industry-funded studies, such as those partially supported by the Titanium Dioxide Manufacturers Association, frequently report no significant adverse effects, contrasting sharply with findings from publicly funded independent studies.12 This discrepancy highlights the need for transparent, independent research to inform public health decisions genuinely.
Given titanium dioxide’s pervasive presence in food and unresolved safety concerns, regulatory inertia is troubling. While animal and mechanistic studies accumulate concerning evidence, the absence of direct human epidemiological data should not lull policymakers into complacency. Rather, it should prompt caution, rigorous independent research, and a precautionary stance in regulatory frameworks worldwide.
References
1. Weir A, Westerhoff P, Fabricius L, Hristovski K, Von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012;46(4):2242-2250. doi:10.1021/es204168d “This study quantifies the amount of titanium in common food products, derives estimates of human exposure to dietary (nano-) TiO2, and discusses the impact of the nanoscale fraction of TiO2 entering the environment. The foods with the highest content of TiO2 included candies, sweets, and chewing gums. Among personal care products, toothpastes and select sunscreens contained 1% to >10% titanium by weight. While some other crèmes contained titanium, despite being colored white, most shampoos, deodorants, and shaving creams contained the lowest levels of titanium (<0.01 μg/mg). For several high-consumption pharmaceuticals, the titanium content ranged from below the instrument detection limit (0.0001 μg Ti/mg) to a high of 0.014 μg Ti/mg.”
2. International Agency for Research on Cancer (IARC). Titanium Dioxide. IARC Monographs Volume 93. Lyon, France: IARC; 2010. Available from: https://publications.iarc.who.int/_publications/media/download/2865/mono93-7.pdf
3. European Food Safety Authority (EFSA). Titanium dioxide: E171 no longer considered safe when used as a food additive. Published 2021. Accessed February 2026. https://www.efsa.europa.eu/en/news/titanium-dioxide-e171-no-longer-considered-safe-when-used-food-additive
4. European Commission. Commission Regulation (EU) 2022/63 removing titanium dioxide (E171). Official Journal of the European Union. Published January 18, 2022. Accessed February 2026. https://eur-lex.europa.eu/eli/reg/2022/63/oj/eng
5. Food Standards Australia New Zealand (FSANZ). Review of titanium dioxide as a food additive. Published 2022. Accessed February 2026. https://www.foodstandards.gov.au/consumer/foodtech/Review-of-titanium-dioxide-as-a-food-additive
6. US Food and Drug Administration (FDA). Titanium dioxide: 21 CFR § 73.575. Accessed February 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-73/subpart-A/section-73.575
7. Bettini S, Boutet-Robinet E, Cartier C, et al. Food-grade TiO₂ impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions, and promotes aberrant crypt development in the rat colon. Sci Rep. 2017;7:40373. doi:10.1038/srep40373
8. Cao X, et al. Foodborne Titanium Dioxide Nanoparticles Induce Stronger Adverse Effects in Obese Mice than Non-Obese Mice: Gut Microbiota Dysbiosis, Colonic Inflammation, and Proteome Alterations. Small. 2020;16(36):e2001858. doi:10.1002/smll.202001858
9. Chemours. Ti-Pure Titanium Dioxide SDS. Accessed February 2026. https://www.chempoint.com/products/download?doctype=sds&grade=74688
10. Tronox Limited. Titanium Dioxide SDS. Accessed February 2026. https://www.tronox.com/download.php?path=16590
11. Sigma-Aldrich. Titanium dioxide Safety Data Sheet. Accessed February 2026. https://www.sigmaaldrich.com/FR/en/sds/aldrich/718467
12. Blevins LK, Crawford RB, Bach A, et al. Evaluation of immunologic and intestinal effects in rats administered an E171-containing diet. Food Chem Toxicol. 2019;133:110793.
IPAK-EDU is grateful to Popular Rationalism as this piece was originally published there and is included in this news feed with mutual agreement. Read More
Leave a Reply